Changing the Way We Do Diagnostics One Ear at a Time

The report in today’s Health Imaging internet news, “Got an iPhone? Image an Ear Infection.” May not mean much to IAMERS members immediately, but spend a few moments, read the short news story and consider where diagnostic medicine is heading. 15 million visits each year to the pediatrician just for ear infections. With this app and phone attachment the parent can take a picture and transmit it to the doctor. The image will give the physician information separating ear infections that need antibiotics from those that do not. Continue Reading…

CCTA Use Growing as End-users Struggle with Appropriate Utilization

Cardiac CT Angiography (CCTA) is growing as it should. As with any new applications in diagnostic medicine there are incidences of inappropriate use. However, the ability for this technology to identify those without significant coronary artery disease (CAD) is significant. The test is less expensive than cardiac catheterization and certainly brings with it much lower risk. CCTA is here to stay for screening those suspected of CAD and possibly needing intervention. With the increasing numbers of cardiology practices joining hospitals the use of this application will grow and its appropriate use will become more apparent to those who order the test.

http://www.cardiovascularbusiness.com/index.php?option=com_articles&article=35058

 

Limbo for CT Dose. How Low Can It Go?

The radiology community over the past three years has really taken it on the chin for unnecessary patient exposure to ionizing radiation. The report from HealthImaging this morning and linked here is the latest of many showing how to alter the dose to the patient and still get acceptable diagnostic scans. We’re heading in the right direction.

CCTA, SPECT or PET Which One Is Best for Diagnosing CAD?

The latest article from Radiology, August 8, 2012, was reported on by HealthImaging.  The results seem conclusive that CCTA can now be depended upon for raising the bar for diagnosing CAD in patients with previously abnormal SPECT scans. But do the results tell the whole story? That’s the question to be answered. Clearly the specificity is better with CCTA but the authors admit the SPECT studies were performed at many sites and not standardized by equipment or protocol. The CCTA was done in a standardized manner. PET might have provided a better result than the other two but what are we seeking? It appears we are still technology centric rather than disease centric.

Read the report at HealthImaging and think about where we go from here.

Page 87 of 93« First...102030...8586878889...Last »